Amzeeq (minocycline foam 4%) for topical treatment of acne vulgaris

Skinmed. 2020 Dec 1;18(6):354-357. eCollection 2020.

Authors

Aditya K Gupta^{1

2}, Anthony Bruce³, Kimberly Dawn Vincent⁴, William Abramovits^{4

5

6}

Affiliations

¹ Division of Dermatology, Department of Medicine, University of Toronto School of Medicine, Toronto, Ontario, Canada.
² Mediprobe Research Inc., London, Ontario, Canada; agupta@execulink.com.
³ Mediprobe Research Inc., London, Ontario, Canada.
⁴ Belle Meade Dermatology, Nashville Tennessee.
⁵ Department of Medicine, Baylor University Medical Center.
⁶ Dermatology Treatment and Research Center, Dallas, TX.

PMID: 33397564

No abstract available

MeSH terms

Acne Vulgaris / drug therapy*
Acne Vulgaris / microbiology
Administration, Cutaneous
Anti-Bacterial Agents / administration & dosage
Anti-Bacterial Agents / adverse effects
Anti-Bacterial Agents / pharmacokinetics
Humans
Minocycline / administration & dosage*
Minocycline / adverse effects
Minocycline / pharmacokinetics

Substances

Anti-Bacterial Agents
Minocycline